Helix BioPharma Corp. (TSX:HBP)
1.830
-0.260 (-12.44%)
Jan 22, 2026, 3:58 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 159.63 million as of January 22, 2026. Its market cap has increased by 173.64% in one year.
Market Cap
159.63M
Enterprise Value
159.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.83
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 159.63M, an increase of 1,601.20%. That is a compound annual growth rate of 9.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 159.63M | -11.81% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.58B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.17B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 1.96B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |